Takeda's Entyvio Beats Humira In Head-To-Head Ulcerative Colitis Trial

 
• By John Davis
Heads
Blinded double-dummy head-to-head studies may be key to driving change in the IBD marketplace • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas